Back to search

Peptide record

TPDB43134

VS-9 Anticancer standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43134
VS-9
Anticancer
Cancer-related peptides
CancerPPD 2.0 dbACP
standard
No
A 9-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0 and dbACP, with an available 3D structural model.
Sequence
VKLRSLLCS
Physicochemical Analysis
C44H83N13O12S1
ANDEQGHIMFPTWY
L
1018.28
10.11
2
0
4
+2
0.21
0.900
162.22
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
0
A
1
R
0
N
0
D
1
C
0
E
0
Q
0
G
0
H
0
I
3
L
1
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 1 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 3 K: 1 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
9
C44H83N13O12S1
1018.28
10.11
+2
0.21
0.900
Free
L
Linear
Free
Anticancer
Allium sativum
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 0.84 mM
Anticancer
0.84 mM

Target

Blood Cancer
MOLT-4
Blood

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 1.57 mM
Anticancer
1.57 mM

Target

Blood Cancer
K-562
Blood

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2021